ConductScience.org, home

Paper28115367

LGL leukemia: from pathogenesis to treatment.

Lamy T and 2 others. Blood, 2017. Cited by 257 papers, by iCite.

Cite this record

ConductScience Library. LGL leukemia: from pathogenesis to treatment. Papers, record 28115367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28115367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
LGL leukemia: from pathogenesis to treatment.
PubMed
Journal
Blood
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
257
iCite
Relative citation ratio, by iCite
9.11
iCite
Revised in PubMed
2022-04-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lamy TThierry
2Moignet AAline
3Loughran TP JrThomas P

Source PubMed

Download CSV of authors

Topics2

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, Large Granular LymphocyticMajor topic
Humans

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04453345TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLLBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by191

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 257 citations.

PMIDTitleJournalYearIn PapersSource
42911123TLR8 gain-of-function syndrome.J Hum Immun2026https://conductscience.org/library/papers/42911123PubMed
42807682Felty Syndrome-Associated Clonal Cytotoxic T-Cell Disease With Terminal Aggressive Progression: Shared STAT3 and TET2 Mutations Across a Prolonged Disease Course.EJHaem2026https://conductscience.org/library/papers/42807682PubMed
42706158[Efficacy and safety of a JAK1 inhibitor for relapsed/refractory large granular lymphocytic leukemia].Zhonghua Xue Ye Xue Za Zhi2026https://conductscience.org/library/papers/42706158PubMed
42706151[Chinese expert consensus on the diagnosis and treatment of large granular lymphocytic leukemia (2026)].Zhonghua Xue Ye Xue Za Zhi2026https://conductscience.org/library/papers/42706151PubMed
42642781From molecular pathogenesis to novel Therapeutic approaches - a review of recent advances in the treatment of peripheral T cell Lymphomas.Biomark Res2026https://conductscience.org/library/papers/42642781PubMed
42577896TCR γδ cell-specific STAT5 gain of function induces a druggable chronic human immune dysregulation.J Hum Immun2026https://conductscience.org/library/papers/42577896PubMed
42511571Clinical Manifestations and Genetic Profile of Chinese Patients with NK-Cell Large Granular Lymphocytic Leukemia-A Single-Center Retrospective Analysis.Int J Mol Sci2026https://conductscience.org/library/papers/42511571PubMed
42455308Simultaneous onset of familial hemophagocytic lymphohistiocytosis and T-cell large granular lymphocytic leukemia in an adult.Ann Hematol2026https://conductscience.org/library/papers/42455308PubMed
42371119A case report of CD4- CD8+ CD56- TCRγδ+ T-large granular lymphocytic leukaemia with severe aplastic anemia and a PNH clone.Ann Hematol2026https://conductscience.org/library/papers/42371119PubMed
42120292Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis.Ann Rheum Dis2026https://conductscience.org/library/papers/42120292PubMed
41991314[A single-center study on the clinical characteristics of 15 cases of large granular lymphocytic leukemia].Zhonghua Xue Ye Xue Za Zhi2026https://conductscience.org/library/papers/41991314PubMed
41646969Clinical features and influencing factors analysis of T-cell large granular lymphocytic leukemia complicated with pure red cell aplasia.Front Immunol2025https://conductscience.org/library/papers/41646969PubMed
41554568Peripheral versus Marrow Lipidomics in Patients with Severe Aplastic Anemia: Potential Indicators for Early Immunosuppressive Treatment Response.Lipids2026https://conductscience.org/library/papers/41554568PubMed
41511789Immune-Driven Expression in Inclusion Body Myositis With T-Cell Large Granular Lymphocytic Leukemia.Ann Clin Transl Neurol2026https://conductscience.org/library/papers/41511789PubMed
41445878Analysis of Treatment Outcome in Large Granular Lymphocytic Leukemia: A Retrospective Study from India.South Asian J Cancer2025https://conductscience.org/library/papers/41445878PubMed
41317167Restricted Expression of the Constant Region 1 of T-Cell Receptor β by Flow Cytometry Facilitates Detection of T-Cell Neoplasms With High Specificity but Moderate Predictive Value.Eur J Haematol2026https://conductscience.org/library/papers/41317167PubMed
41303704The Significance of the Microenvironment in T/Nk-Cell Neoplasms.Int J Mol Sci2025https://conductscience.org/library/papers/41303704PubMed
41191533Diagnostic criteria for NK cell large granular lymphocyte leukemia: validation through a multicentric international study.Blood Adv2026https://conductscience.org/library/papers/41191533PubMed
41170887T-Cell Large Granular Lymphocytic Leukemia Presenting as Isolated Transfusion-Dependent Anemia Without Autoimmune Disease: A Case Report.J Investig Med High Impact Case Rep2025https://conductscience.org/library/papers/41170887PubMed
41025032Newly diagnosed T-large granular lymphocyte Leukemia presenting with severe neutropenia: a case report.Oxf Med Case Reports2025https://conductscience.org/library/papers/41025032PubMed

See all 191 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
IL153600PubTator's text mininghttps://conductscience.org/library/genes/3600NCBI Gene
MAP2K15604PubTator's text mininghttps://conductscience.org/library/genes/5604NCBI Gene
PIK3R15295PubTator's text mininghttps://conductscience.org/library/genes/5295NCBI Gene
SOCS39021PubTator's text mininghttps://conductscience.org/library/genes/9021NCBI Gene
STAT36774PubTator's text mininghttps://conductscience.org/library/genes/6774NCBI Gene
STAT5B6777PubTator's text mininghttps://conductscience.org/library/genes/6777NCBI Gene
TNFAIP37128PubTator's text mininghttps://conductscience.org/library/genes/7128NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28115367

GET https://conductscience.org/api/papers/v1/28115367/cited_by?page=2